Clause 8.2 sets the criteria for pharmaceutical product identification and then works through special cases. The public contents name six. One is the general consideration. One covers a kit whose products are given as separate medicinal products. One covers a kit for reconstitution that is given as a single medicinal product. One covers kit components that are not packed together, such as radiopharmaceutical kits. One covers the same product authorised with different strength representations in two or more regions. One covers how the identifier is represented for a patch. The list is a catalogue of the cases that break a naive model. The detailed criteria for each case are not in the public preview and are not stated in the text we hold. What the list proves is that the document expects the identifier to be assigned with a judgement, not by a lookup on the pack.
The graph holds this control, the 0 it maps to, and the evidence behind each claim, over MCP and REST.